vs

Side-by-side financial comparison of ARVINAS, INC. (ARVN) and HomeTrust Bancshares, Inc. (HTB). Click either name above to swap in a different company.

HomeTrust Bancshares, Inc. is the larger business by last-quarter revenue ($53.6M vs $41.9M, roughly 1.3× ARVINAS, INC.). On growth, HomeTrust Bancshares, Inc. posted the faster year-over-year revenue change (3.7% vs -59.1%). HomeTrust Bancshares, Inc. produced more free cash flow last quarter ($45.3M vs $-59.2M). Over the past eight quarters, ARVINAS, INC.'s revenue compounded faster (10.0% CAGR vs 3.5%).

Arvinas, Inc. is a clinical-stage biotechnology company focused on developing targeted protein degradation therapies, including PROTAC molecules, to treat cancer and rare diseases. It operates primarily in the U.S. and global biopharma markets, advancing multiple pipeline candidates through clinical trials to address unmet medical needs.

HomeTrust Bancshares Inc. is an Asheville, North Carolina–based bank holding company with $4.3 billion in assets and 33 branches in North and South Carolina, Georgia and Tennessee. It is the parent of seven community banks—HomeTrust Bank, Tryon Federal Bank, Shelby Savings Bank, Home Savings Bank, Industrial Federal Bank, Cherryville Federal Bank and Rutherford County Bank.

ARVN vs HTB — Head-to-Head

Bigger by revenue
HTB
HTB
1.3× larger
HTB
$53.6M
$41.9M
ARVN
Growing faster (revenue YoY)
HTB
HTB
+62.7% gap
HTB
3.7%
-59.1%
ARVN
More free cash flow
HTB
HTB
$104.5M more FCF
HTB
$45.3M
$-59.2M
ARVN
Faster 2-yr revenue CAGR
ARVN
ARVN
Annualised
ARVN
10.0%
3.5%
HTB

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
ARVN
ARVN
HTB
HTB
Revenue
$41.9M
$53.6M
Net Profit
$-35.1M
Gross Margin
Operating Margin
-104.5%
37.0%
Net Margin
-83.8%
Revenue YoY
-59.1%
3.7%
Net Profit YoY
28.7%
EPS (diluted)
$-0.48
$0.93

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARVN
ARVN
HTB
HTB
Q4 25
$53.6M
Q3 25
$41.9M
$54.1M
Q2 25
$54.4M
Q1 25
$188.8M
$50.9M
Q4 24
$59.2M
$51.7M
Q3 24
$102.4M
$50.6M
Q2 24
$76.5M
$50.6M
Q1 24
$25.3M
$50.0M
Net Profit
ARVN
ARVN
HTB
HTB
Q4 25
Q3 25
$-35.1M
$16.5M
Q2 25
$17.2M
Q1 25
$82.9M
$14.5M
Q4 24
$-45.1M
Q3 24
$-49.2M
$13.1M
Q2 24
$-35.2M
$12.4M
Q1 24
$-69.4M
$15.1M
Operating Margin
ARVN
ARVN
HTB
HTB
Q4 25
37.0%
Q3 25
-104.5%
38.5%
Q2 25
40.1%
Q1 25
37.8%
36.2%
Q4 24
-98.1%
35.4%
Q3 24
-58.9%
33.2%
Q2 24
-63.4%
31.3%
Q1 24
-329.2%
38.0%
Net Margin
ARVN
ARVN
HTB
HTB
Q4 25
Q3 25
-83.8%
30.5%
Q2 25
31.6%
Q1 25
43.9%
28.5%
Q4 24
-76.2%
Q3 24
-48.0%
25.9%
Q2 24
-46.0%
24.6%
Q1 24
-274.3%
30.1%
EPS (diluted)
ARVN
ARVN
HTB
HTB
Q4 25
$0.93
Q3 25
$-0.48
$0.95
Q2 25
$1.00
Q1 25
$1.14
$0.84
Q4 24
$-0.63
$0.83
Q3 24
$-0.68
$0.76
Q2 24
$-0.49
$0.73
Q1 24
$-0.97
$0.88

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARVN
ARVN
HTB
HTB
Cash + ST InvestmentsLiquidity on hand
$787.6M
$324.7M
Total DebtLower is stronger
$600.0K
Stockholders' EquityBook value
$564.4M
$600.7M
Total Assets
$844.3M
$4.5B
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARVN
ARVN
HTB
HTB
Q4 25
$324.7M
Q3 25
$787.6M
$315.8M
Q2 25
$297.2M
Q1 25
$954.3M
$299.8M
Q4 24
$1.0B
$279.2M
Q3 24
$1.1B
$293.5M
Q2 24
$1.2B
$294.2M
Q1 24
$1.2B
$380.5M
Total Debt
ARVN
ARVN
HTB
HTB
Q4 25
Q3 25
$600.0K
Q2 25
Q1 25
$700.0K
Q4 24
$800.0K
Q3 24
$800.0K
Q2 24
$900.0K
Q1 24
$900.0K
Stockholders' Equity
ARVN
ARVN
HTB
HTB
Q4 25
$600.7M
Q3 25
$564.4M
$595.8M
Q2 25
$579.3M
Q1 25
$660.1M
$565.4M
Q4 24
$561.7M
$551.8M
Q3 24
$586.0M
$540.0M
Q2 24
$600.2M
$523.6M
Q1 24
$609.7M
$513.2M
Total Assets
ARVN
ARVN
HTB
HTB
Q4 25
$4.5B
Q3 25
$844.3M
$4.6B
Q2 25
$4.6B
Q1 25
$1.0B
$4.6B
Q4 24
$1.1B
$4.6B
Q3 24
$1.2B
$4.6B
Q2 24
$1.3B
$4.7B
Q1 24
$1.2B
$4.7B
Debt / Equity
ARVN
ARVN
HTB
HTB
Q4 25
Q3 25
0.00×
Q2 25
Q1 25
0.00×
Q4 24
0.00×
Q3 24
0.00×
Q2 24
0.00×
Q1 24
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARVN
ARVN
HTB
HTB
Operating Cash FlowLast quarter
$-59.1M
$49.5M
Free Cash FlowOCF − Capex
$-59.2M
$45.3M
FCF MarginFCF / Revenue
-141.3%
84.5%
Capex IntensityCapex / Revenue
0.2%
7.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-361.6M
$93.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARVN
ARVN
HTB
HTB
Q4 25
$49.5M
Q3 25
$-59.1M
$-11.3M
Q2 25
$-8.8M
Q1 25
$-88.9M
$71.7M
Q4 24
$-84.1M
$45.4M
Q3 24
$-128.0M
$43.8M
Q2 24
$50.3M
$5.9M
Q1 24
$-97.5M
$-9.0M
Free Cash Flow
ARVN
ARVN
HTB
HTB
Q4 25
$45.3M
Q3 25
$-59.2M
$-12.0M
Q2 25
$-10.2M
Q1 25
$-89.3M
$70.7M
Q4 24
$-84.4M
$42.4M
Q3 24
$-128.7M
$43.1M
Q2 24
$49.6M
$5.7M
Q1 24
$-97.6M
$-9.6M
FCF Margin
ARVN
ARVN
HTB
HTB
Q4 25
84.5%
Q3 25
-141.3%
-22.2%
Q2 25
-18.7%
Q1 25
-47.3%
138.7%
Q4 24
-142.6%
82.0%
Q3 24
-125.7%
85.1%
Q2 24
64.8%
11.2%
Q1 24
-385.8%
-19.2%
Capex Intensity
ARVN
ARVN
HTB
HTB
Q4 25
7.8%
Q3 25
0.2%
1.4%
Q2 25
2.5%
Q1 25
0.2%
2.0%
Q4 24
0.5%
5.9%
Q3 24
0.7%
1.3%
Q2 24
0.9%
0.5%
Q1 24
0.4%
1.1%
Cash Conversion
ARVN
ARVN
HTB
HTB
Q4 25
Q3 25
-0.68×
Q2 25
-0.51×
Q1 25
-1.07×
4.93×
Q4 24
Q3 24
3.34×
Q2 24
0.48×
Q1 24
-0.60×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons